Subcutaneous implantable cardiac defibrillation system
AssigneeSorin Crm SAS
InventorsThierry Legay, Rafael Cordero Alvarez, Delphine Feuerstein
Life of this patent
Estimating the term…
Loading patent…
AssigneeSorin Crm SAS
InventorsThierry Legay, Rafael Cordero Alvarez, Delphine Feuerstein
Estimating the term…
A subcutaneous cardiac defibrillation system implantable comprising a housing and a subcutaneous implantable lead comprising a proximal end connected to the housing and a distal free end. The subcutaneous implantable lead comprises at least one defibrillation electrode and at least three detection electrodes. The first detection electrode and the second detection electrode form a first dipole, and the third detection electrode and the first detection electrode, or the third detection electrode and the second detection electrode, or the housing and one of said detection electrodes, form a second dipole. The defibrillation electrode is positioned between the second detection electrode and the third detection electrode, the first dipole is positioned between the housing and the defibrillation electrode, the third electrode is positioned between the free distal end of the lead and the defibrillation electrode, and the length of the first dipole is shorter than the length of the second dipole.
A subcutaneous implantable cardiac defibrillation system comprising:
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
Electrodes: for implantation or insertion into the body, e.g. heart electrode
Heart defibrillators: implantable devices for applying electric shocks to the heart, e.g. for cardioversion
Constructional arrangements, e.g. casings: details of casing-lead connections
Heart defibrillators: monitoring; Protecting
About 13 years 9 months of term left · ends 17 Jul 2040 (estimated)
This application claims the benefit of and priority to French Application No. 1907532, filed Jul. 5, 2019, which is incorporated herein by reference in its entirety.
The present invention relates to a subcutaneous implantable cardiac defibrillation system.
Conventional implantable automatic defibrillators, i.e. of transvenous type, also abbreviated ICD for “Implantable Cardioverter-Defibrillator”, comprise a defibrillation pulse generator and a microprocessor control unit housed in a metal case usually implanted in the chest pocket. This box is connected to one or more leads which are introduced into the subclavian vein where they finally reach the heart. Inside the heart, the distal ends of the leads are attached to the inner walls of the heart chambers, where they can record electrograms (EGMs) reflecting the electrophysiological functioning of the heart. Based on these, defibrillation therapy (defibrillation shock) is administered (or discontinued) to end a life-threatening ventricular tachyarrhythmia, such as ventricular tachycardia and ventricular fibrillation.
The invention and its advantages will be explained in more detail below by means of preferred embodiments and based in particular on the following accompanying figures, wherein:
FIG. 1 represents a schematic plot of a normal electrocardiogram;
FIG. 2 represents a schematic view of a subcutaneous implantable cardiac defibrillation system according to the present invention;
The invention will now be described in more detail using advantageous embodiments in an exemplary method and with reference to FIGS. 2 and 3. The embodiments described are simply possible configurations and it should be borne in mind that the individual characteristics as described above can be provided independently of each other or can be omitted altogether when practicing the present invention.
FIG. 2 illustrates a cardiac defibrillation system implantable under the skin 10. FIG. 3 illustrates said system 10 in an implanted state.
The subcutaneous implantable cardiac defibrillation system 10 comprises a pulse generator housing 12, to which a subcutaneous implantable lead 14 is connected. The subcutaneous implantable cardiac defibrillation system 10 is capable of delivering a defibrillation shock.